Literature DB >> 2880837

ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.

G Addonizio, V L Susman.   

Abstract

The use of ECT as a treatment alternative in a clinical situation in which it is difficult to determine whether the patient is suffering from neuroleptic malignant syndrome (NMS) or an evolving catatonic state is investigated. Fourteen cases from the literature are reviewed and 3 new cases are presented. In 6 cases, ECT was rapidly effective in treating symptoms of NMS, but cardiac arrhythmias were reported in 4 cases. There was no evidence of malignant hyperthermia (MH) in patients receiving succinylcholine, suggesting that an association between NMS and MH may not be clinically relevant in patients being treated with ECT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2880837

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Electroconvulsive therapy in a schizophrenic patient with neuroleptic malignant syndrome and pulmonary embolism: a case report.

Authors:  Hitesh N Pandya; Michael J Keyes; Brian C Christenson
Journal:  Psychiatry (Edgmont)       Date:  2007-04

Review 2.  Neuroleptic malignant syndrome--follow-up study.

Authors:  P Buckley; A Freyne; A McCarthy; C Larkin
Journal:  Ir J Med Sci       Date:  1991-02       Impact factor: 1.568

Review 3.  Treatment of movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 4.  Movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

5.  Neuroleptic Malignant Syndrome: A Primary Care Perspective.

Authors:  Sanjay Gupta; Nikhil D Nihalani
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

6.  Neuroleptic malignant syndrome: a case for electroconvulsive therapy.

Authors:  C C Harland; M M O'Leary; R Winters; J Owens; B Hayes; V Melikian
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

Review 7.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

Review 8.  Neuroleptic malignant syndrome.

Authors:  M S Jahan; A I Farooque; Z Wahid
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.